News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Breen Michael Martin
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/15/2023 |
4
| Breen Michael Martin (Executive Chairman/Interim CEO) has filed a Form 4 on GT Biopharma, Inc.
Txns:
| Granted 200,000 shares
@ $0.287, valued at
$57.4k
|
|
05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/12/2021 |
4
| Breen Michael Martin (Director) has filed a Form 4 on GT Biopharma, Inc.
Txns:
| Converted 100,000 options to buy
@ $3.4, valued at
$340k
Converted 30,000 options to buy
@ $3.4, valued at
$102k
Granted 278,058 shares
@ $0 Converted 40,243 shares
@ $3.4, valued at
$136.8k
Converted 9,859 shares
@ $3.4, valued at
$33.5k
Granted 50,000 options to buy
@ $6.33, valued at
$316.5k
|
|
11/12/2021 |
3
| Breen Michael Martin (Director) has filed a Form 3 on GT Biopharma, Inc. |
|
|